NewsSyngene International Schedules Board Meeting for April 29, 2026 to Review Q4FY26 Results and Consider Final DividendSyngene International Schedules Board Meeting for April 29, 2026 to Review Q4FY26 Results and Consider Final Dividend
Syngene International Limited has scheduled its board meeting for April 29, 2026, to consider and approve audited standalone and consolidated financial results for Q4FY26 and the full year ending March 31, 2026. The board will also deliberate on final dividend recommendations among other routine matters. The company has closed its trading window for insiders from April 01, 2026 until May 01, 2026, in compliance with SEBI regulations. A conference call for analysts and investors is planned for April 30, 2026, with details to be available on the company website.
*this image is generated using AI for illustrative purposes only.
Syngene International Limited has formally notified the stock exchanges about an upcoming board meeting scheduled to review its financial performance and consider dividend distribution for shareholders.
Board Meeting Details
The company has announced that its Board of Directors will convene on Wednesday, April 29, 2026, to undertake several key agenda items. The meeting has been scheduled in compliance with Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
| Meeting Details: | Information |
|---|---|
| Date: | April 29, 2026 |
| Day: | Wednesday |
| Primary Agenda: | Q4FY26 and Annual Results |
| Additional Items: | Final dividend consideration |
Key Agenda Items
The board will consider and approve the audited standalone and consolidated financial results for the quarter and year ending March 31, 2026. Additionally, the directors will deliberate on the recommendation of final dividend, if any, amongst other routine matters that typically form part of such meetings.
Trading Window Restrictions
In accordance with regulatory compliance, the company has implemented mandatory trading restrictions for insiders. The trading window for dealing in securities has been closed from April 01, 2026, and will remain shut until the close of trading hours on May 01, 2026.
| Trading Window Details: | Timeline |
|---|---|
| Closure Start: | April 01, 2026 |
| Closure End: | May 01, 2026 (close of trading) |
| Duration: | Until 48 hours after results declaration |
| Compliance: | SEBI Insider Trading Regulations |
This closure period extends until 48 hours after the declaration of financial results, ensuring compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as well as the company's internal code of conduct for Prevention of Insider Trading.
Investor Engagement
Syngene International will organize a conference call for analysts and investors on Thursday, April 30, 2026, following the board meeting. The company has indicated that detailed information regarding the conference call will be made available on its official website closer to the scheduled event, allowing stakeholders to participate in the earnings discussion and seek clarifications on the financial performance.
Historical Stock Returns for Syngene International
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.75% | +8.93% | +3.29% | -30.79% | -39.74% | -24.11% |
What factors might influence Syngene's dividend policy decision given the current pharmaceutical services market conditions?
How could Syngene's Q4FY26 results impact its competitive positioning in the contract research and manufacturing sector?
What strategic initiatives might Syngene announce during the investor conference call to drive future growth?
19
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
